NCT00524524 An Exploratory Biomarker Study of ARQ 501 in Patients With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT00520637 A Phase I, Study to Evaluate the Safety and Tolerability of Intravenous EZN-2208 in Patients With Advanced Solid Tumors or Lymphoma (EZN-2208-01) Status COMPLETED Phase PHASE1
NCT00520390 A Phase I, Study to Evaluate the Safety and Tolerability of Intravenous EZN-2208 in Patients With Advanced Solid Tumors or Lymphoma (EZN-2208-02) Status COMPLETED Phase PHASE1
NCT00519662 Safety and Tolerability Study of SNS-314 for Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT00507585 Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, Leucovorin, and Avastin Status COMPLETED Phase PHASE1
NCT00487058 A Phase I Dose Escalation Study of LBQ707 (Gimatecan) Administered Orally Twice Per Week to Japanese Patients With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT00473616 Phase I Single Ascending Dose/Multiple Ascending Dose in Patients Treated With AZD7762 and Irinotecan Status TERMINATED Phase PHASE1
NCT00441610 An Extension Trial to a Phase I Dose Escalation Study of Gimatecan Administered Orally 5 Consecutive Days to Japanese Patients With Advanced Solid Tumor Status COMPLETED Phase PHASE1
NCT00426582 Combination Trial of Patupilone and Carboplatin in Adult Patients With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT00419328 A Modified Phase I Study of NGR-hTNF in Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT00410358 A Dose Escalation of Gimatecan Administered Orally to Japanese Patients With Advanced Solid Tumor. Status COMPLETED Phase PHASE1
NCT00359671 Treatment With MK6592 and an Anti-cancer Drug in Patients With Advanced Solid Tumors (6592-001) Status TERMINATED Phase PHASE1
NCT00207129 Effect of Capecitabine on the Pharmacokinetics of BMS-247550 and BMS-247550 on the Pharmacokinetics of Capecitabine and Its Metabolites in Patients With Advanced Malignancies Status COMPLETED Phase PHASE1
NCT00207090 Effect of Rifampin on the Pharmacokinetics of Ixabepilone in Patients With Advanced Cancer Status COMPLETED Phase PHASE1
NCT00139620 A Pharmacokinetic Study of Erlotinib in Cancer Patients With Advanced Solid Tumors, With Adequate and Moderately Impaired Hepatic Function Status COMPLETED Phase PHASE1